RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 45-55
  • Salix Pharmaceuticals drops tax inversion deal amid backlash

    Salix Pharmaceuticals drops tax inversion deal amid backlash
    Salix Pharmaceuticals called off its merger with a foreign drug maker Friday, citing the political backlash against tax inversion deals. The deals—in which a company reincorporates abroad to gain lower taxes—drew fire this summer after...
  • UK cost agency rejects British company GW's cannabis drug

    LONDON (Reuters) - A pioneering cannabis drug developed by British firm GW Pharmaceuticals for treating spasticity in multiple sclerosis has been rejected as not cost-effective in the company's home market. The National Institute for Health and Care...
  • Exclusive: Actavis plans new merger approach for Allergan - sources

    NEW YORK (Reuters) - Actavis Plc plans to approach Allergan Inc again about a potential merger, as the Botox maker warms up to the possibility of a sale, people familiar with the matter said on Tuesday. Allergan, which has repeatedly rejected offers from...
  • Why we allow Big Pharma to rip us off [Commentary]

    Why we allow Big Pharma to rip us off [Commentary]
    According to a new federal database put online last week, pharmaceutical companies and device makers paid doctors some $380 million in speaking and consulting fees over a five-month period in 2013. Some doctors received over $500,000 each, and some...
  • Q&A: States and drug prices

    WASHINGTON The new hepatitis C drug Sovaldi promises a cure rate of well over 90 percent, compared with 45 percent (at best) for older drugs. But when Sovaldi went on the market earlier this year for as much as $84,000 for a single course of treatment,...
  • Chimerix drug used for Ebola shows promise in respiratory cases

    (Reuters) - Chimerix Inc said its experimental oral antiviral, which was used earlier this week to treat the first Ebola patient diagnosed in the United States, improved the survival rate of patients with a certain type of respiratory infection....
  • Dogs, hogs and dairy cows: 'Animal pharm' catches Wall Street's attention

    OVERLAND PARK Kan. (Reuters) - Cancer drugs for cats, pain relief for dogs, diarrhea drugs for hogs and hormones for dairy cattle: The "animal pharm" industry is increasingly drawing the interest of Wall Street investors. One of the newest companies...
  • Ebola drug maker Chimerix's stock tumbles after Dallas patient dies

    Shares of Chimerix Inc., the maker of an experimental drug to combat Ebola, sank Wednesday after the death in Dallas of a patient with the disease who received the medicine. About two hours after officials announced the death of Thomas Eric Duncan,...
  • Texas Ebola patient still critical, now receiving experimental drug

    A Liberian man being treated for Ebola in a Dallas hospital is still in critical condition, but is now receiving an experimental treatment. Thomas Eric Duncan has been in isolation at Texas Health Presbyterian Hospital since Sept. 28, after he came down...
  • New database details payments from medical companies to local doctors

    New database details payments from medical companies to local doctors
    — During the last five months of 2013, Lehigh Valley medical-device manufacturers spent more than $2 million on food, travel, speaking fees and other payments to doctors and hospitals that the companies want to see using and promoting their...
  • Chimerix says provides experimental Ebola drug for potential use

    (Reuters) - Drug developer Chimerix Inc said its experimental Ebola drug has been provided for potential use in patients, sending its shares up nearly 9 percent in premarket trading. The drug, brincidofovir, received Emergency Investigational New Drug...